(Press-News.org) HOUSTON - (Feb. 15, 2021) - Collagen is the king of biological proteins, and now it has a SCEPTTr.
That's the handle of an algorithm developed by Rice University scientists who study natural and synthetic versions of collagen, which accounts for about a third of the body's proteins and forms the fibrous glue in skin, bones, muscles, tendons and ligaments.
The program -- full name, Scoring function for Collagen-Emulating-Peptides' Temperature of Transition -- accurately predicts the stability of collagen triple helices, the primary structure that forms fibrils.
The Rice team led by chemist and bioengineer Jeffrey Hartgerink and graduate student Douglas Walker tested SCEPTTr on 431 collagen triple helices from their own experiments and from literature and also used it to guide the design of a novel synthetic collagen helix.
The study in Nature Chemistry could help researchers better understand the critical protein's role in wound healing and cancer and could be used to design synthetic collagens, according to the researchers.
The paper significantly improves upon the lab's 2012 project to predict the stability of synthetic collagen structures. "One of its limitations it that it only understood a very narrow range of amino acids," Hartgerink said.
SCEPTTr expands that to the entire array of natural amino acids. That essentially makes it an Erector set for collagen design, potentially collapsing weeks of trial and error down to seconds on a desktop computer.
"The second major improvement is that while the earlier work couldn't tell you if a species of collagen would be stable at room temperature, Doug's program makes predictions about the melting temperature, the point at which a triple helix falls apart," Hartgerink said. "The great part about that is it's an easily testable value that extends to physiological temperatures as well.
"That's important to us, because if it falls apart when you put it inside a living organism, it's not particularly useful," he said.
SCEPTTr returns more than a single result for a given trio of sequences, detailing all possible combinations of the input peptides and providing a melting temperature for each.
"One of the most important things SCEPTTr does is look at all of the alternative structures that are possible and tells you how stable those are," Walker said. "It helps us understand what these complex mixtures are going to look like before you make them."
Walker brought a unique combination of talents to the project, spending half his time synthesizing collagen peptides and half programming SCEPTTr.
"When I was an undergraduate (studying chemistry at Idaho State University), I kept taking math classes because I really enjoyed it," he explained. "And it got to the point where I thought, 'Well, I'm one class away from a math minor.' And that happened to be a computer science course."
Despite reservations, Walker found he enjoyed programming. "Early on, I said, 'Hey, Doug, do you know anything about computers, because I've got a project for you,'" Hartgerink recalled. "I think the idea was that, if he didn't know about programming, he was going have to figure it out one way or another."
Walker said the program will be freely available online. "We want to make this a more accessible field, and SCEPTTr should make it easier for people to understand collagen," he said.
INFORMATION:
Co-authors of the paper are Rice graduate students Sarah Hulgan and Caroline Peterson, undergraduate Kevin Gonzalez and alumnus I-Che Li. Hartgerink is a professor of chemistry and of bioengineering.
The National Science Foundation, the Robert A. Welch Foundation and a Stauffer-Rothrock Fellowship supported the research.
Read the abstract at https://www.nature.com/articles/s41557-020-00626-6.
This news release can be found online at https://news.rice.edu/2021/02/15/collagen-structures-get-the-royal-reveal/.
Follow Rice News and Media Relations via Twitter @RiceUNews.
Related materials:
Rice University lab encodes collagen: http://news.rice.edu/2012/09/25/rice-university-lab-encodes-collagen-2/
'Sticky' ends start synthetic collagen growth: http://news.rice.edu/2014/10/27/sticky-ends-start-synthetic-collagen-growth-2/
Synthetic collagen promotes natural clotting: http://news.rice.edu/2014/04/09/synthetic-collagen-promotes-natural-clotting-2/
Rice unveils new method to grow synthetic collagen: http://news.rice.edu/2011/09/09/rice-unveils-new-method-to-grow-synthetic-collagen/
Hartgerink Research Group: https://hartgerink.rice.edu
Department of Chemistry: https://chemistry.rice.edu
Department of Bioengineering: https://bioengineering.rice.edu
Images for download:
https://news-network.rice.edu/news/files/2021/02/0119_COLLAGEN-1a-WEB.jpg
An algorithm by Rice University scientists predicts the structures and melting temperatures of collagen, the triple helix that accounts for about a third of the body's proteins and forms the fibrous glue in skin, bones, muscles, tendons and ligaments. (Credit: Douglas Walker/Hartgerink Research Group)
https://news-network.rice.edu/news/files/2021/01/0119_COLLAGEN-2-WEB.jpg
CAPTION: Jeffrey Hartgerink. (Credit: Rice University)
https://news-network.rice.edu/news/files/2021/01/0119_COLLAGEN-3-WEB.jpg
CAPTION: Douglas Walker. (Credit: Rice University)
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,978 undergraduates and 3,192 graduate students, Rice's undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 1 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger's Personal Finance.
Jeff Falk
713-348-6775
jfalk@rice.edu
Mike Williams
713-348-6728
mikewilliams@rice.edu
According to some estimates, chronic pain affects up to 40% of Americans, and treating it frustrates both clinicians and patients--a frustration that's often compounded by a hesitation to prescribe opioids for pain.
A new study from the University of Michigan School of Dentistry confirms that a low dose of a drug called naltrexone is a good option for patients with orofacial and chronic pain, without the risk of addiction, said first author Elizabeth Hatfield, a clinical lecturer in the Department of Oral and Maxillofacial Surgery and Hospital Dentistry.
Naltrexone is a semisynthetic opioid first developed in ...
HOUSTON - (Feb. 15, 2021) - Rice University engineers have suggested a colorful solution to next-generation energy collection: Luminescent solar concentrators (LSCs) in your windows.
Led by Rafael Verduzco and postdoctoral researcher and lead author Yilin Li of Rice's Brown School of Engineering, the team designed and built foot-square "windows" that sandwich a conjugated polymer between two clear acrylic panels.
That thin middle layer is the secret sauce. It's designed to absorb light in a specific wavelength and guide it to panel edges lined with solar cells. Conjugated polymers are chemical compounds ...
Researchers from the University of Southampton and Université Laval, Canada, have successfully measured for the first time back-reflection in cutting-edge hollow-core fibres that is around 10,000 times lower than conventional optical fibres.
This discovery, published this week in The Optical Society's flagship Optica journal, highlights yet another optical property in which hollow-core fibres are capable of outperforming standard optical fibres.
Research into improved optical fibres is key to enable progress in numerous photonic applications. Most notably, these would improve Internet performance ...
Oncotarget recently published "Polymerized human hemoglobin increases the effectiveness of cisplatin-based chemotherapy in non-small cell lung cancer" which reported that unfortunately, a significant portion of NSCLC patients relapse due to cisplatin chemoresistance.
Administration of hemoglobin-based oxygen carriers is a promising strategy to alleviate hypoxia in the tumor, which may make cisplatin more effective.
The R-state PolyHb administered in this study is unable to deliver O2 unless under severe hypoxia which significantly limits its oxygenation potential.
In vitro sensitivity studies indicate that the administration of PolyHb increases the effectiveness of cisplatin under ...
BOSTON -- While PCR testing has been used widely for COVID-19 diagnosis, it only provides information on who is currently infected. Antibody testing can tell who has been previously exposed to SARS-CoV-2, the virus that causes COVID-19, a metric that is essential for tracking spread across a population. It may also, as a study recently published in the journal Nature Communications shows, hold the key to understanding the immune response to the virus.
Led by Galit Alter, PhD, Core Member of the Ragon Institute of MGH, MIT and Harvard, this study found that while antibodies against SARS-CoV-2 may be a good way to measure exposure to the virus, their presence alone wasn't enough to determine if a person had long-lasting protection. Instead, antibody effector functions associated ...
OAK BROOK, Ill. - Radiomics--the extraction of very detailed quantitative features from medical images--provides a refined understanding of how cocaine use and other risk factors affect the course of coronary artery disease, according to a study published in Radiology. Researchers said the study shows the power of radiomics to improve understanding of not just cardiovascular disease, but cancer and other conditions as well.
Coronary artery disease typically develops over time as plaque builds up inside the arteries. This process, known as atherosclerosis, ...
OAK BROOK, Ill. - Researchers using MRI have found significant abnormalities in the eyes of some people with severe COVID-19, according to a study published in the journal Radiology. The study results support the need for eye screening in these patients to provide appropriate treatment and management of potentially severe ophthalmological manifestations of COVID-19.
The COVID-19 pandemic has affected more than 100 million people since it began early in 2020. While the virus primarily attacks the lungs, it has been linked with eye abnormalities ...
Launched in 1988, the Global Polio Eradication Initiative (GPEI) stands out as one of the largest, internationally coordinated global public health major projects conducted to date, with cumulative spending of over $16.5 billion for 1988-2018, according to the World Health Organization (WHO). More than 30 years later, stubborn outbreaks of wild poliovirus still occur in Afghanistan and Pakistan, where cases have been increasing since 2018. The global eradication of polio continues to be an elusive goal.
A special issue of the journal Risk Analysis, titled "Global Poliovirus Risk Management and Modeling," looks at the current status of polio eradication ...
Earth is home to millions of known species of plants and animals, but by no means are they distributed evenly. For instance, rainforests cover less than 2 percent of Earth's total surface, yet they are home to 50 percent of Earth's species. Oceans account for 71 percent of Earth's total surface but contain only 15 percent of Earth's species. What drives this uneven distribution of species on Earth is a major question for scientists.
In a paper published February 16 in the Journal of Biogeography an international team of researchers led by Jacob S. Suissa, Ph.D. Candidate in the Department of Organismic and Evolutionary Biology, ...
Memorial Sloan Kettering Cancer Center (MSK) physicians and scientists presented new research at the 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium held virtually February 11-13. Notably, MSK medical oncologist Robert Motzer, MD, presented encouraging data from a phase III randomized study that assessed two new treatment combinations as first-line treatments that may prolong survival in people with advanced kidney cancer. Dr. Motzer's findings were also published on February 13 in the New England Journal of Medicine.
In this large, international trial involving 200 sites across 20 countries, Dr. Motzer and a team of investigators ...
